Pharma Pulse 3/4/24: Local Pharmacies on the Brink, People in MA Plans Experienced Delays in Accessing Care & more

News
Article

The latest news for pharma industry insiders.

Miha Creative | AdobeStock_522307877

Miha Creative | AdobeStock_522307877

Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act

In an interview with Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now.

Survey Finds People in MA Plans Experienced Delays in Accessing Care

The Commonwealth Fund 2024 Value of Medicare Survey surveyed 3,280 Medicare beneficiaries about access to benefits, services, providers, care coordination, and satisfaction. The survey was conducted by SSRS for the Commonwealth Fund between Nov. 6, 2023, and Jan. 4, 2024 and found about two thirds of older Americans enrolled in Medicare Advantage or traditional plans say their coverage met expectations

This RSV Shot Keeps Babies Out of the Hospital. But Parents Can’t Find It.

A new antibody that protects babies from a deadly virus proved far more popular than drugmaker Sanofi expected

Local Pharmacies on the Brink, New Survey Reveals

As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association recently released a survey showing many local pharmacies are running out of time.

From @IQVIA_Institute on X:

Originally sanctioned for diabetes management as Ozempic, semaglutide's pivot toward weight loss promotion as Wegovy resulted in a surge in purchases and increased the IOP market share. Read more in IQVIA Institute’s report: https://bit.ly/49Rar0j. #Pharma

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs.

© 2024 MJH Life Sciences

All rights reserved.